Skip to content

10+10+30 Infant Vaccines Communication Via Radio in Ethiopia

10+10+30 Infant Vaccines Communication Via Radio in Ethiopia

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04913714
Enrollment
1320
Registered
2021-06-04
Start date
2020-10-13
Completion date
2021-01-31
Last updated
2021-06-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infant ALL

Brief summary

A cohort study to investigate the effectiveness of radio intervention comprising 10-minute of drama, 10-minute of discussion led by community extension workers, and 30-minute phone-in from listeners on childhood vaccination coverage and timeliness

Detailed description

The evaluation is conducted in 2 districts located in the Oromia region of Ethiopia. One of the districts will be allocated to receive the 3-month radio intervention while the other district that will not have access to the radio intervention will serve as the control. Data collection includes survey of mothers at two key times: at baseline (when infants are at most 5 weeks old; but before beginning the intervention) and at endline (including examination of infant vaccination records) at most 21 days after the end of the radio intervention. The same mothers and infants to be followed at endline.

Interventions

BEHAVIORAL3-month radio intervention on infant vaccination

Radio intervention comprising 10-minute drama, 10-minute discussion of the drama by trained health extension workers and 30-minute phone-in from listeners

Sponsors

Jimma University
CollaboratorOTHER
Texas A&M University
CollaboratorOTHER
Bill and Melinda Gates Foundation
CollaboratorOTHER
Syracuse University
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
SINGLE (Outcomes Assessor)

Masking description

Data analyst did not know which group received the intervention

Eligibility

Sex/Gender
ALL
Age
1 Days to 5 Weeks
Healthy volunteers
Yes

Inclusion criteria

Mother, with infant of at most 5 weeks old; Lives in the study district; Consents to participate in study

Exclusion criteria

Mother, with infant of more than 5 weeks old; Does not live in study district; Does not consent to participate in study

Design outcomes

Primary

MeasureTime frameDescription
Penta 3 vaccine coverage of infantup to 3 weeks after the intervention endsInfant's vaccination record or mother's recall based on interviewer-administered questionnaire

Secondary

MeasureTime frameDescription
Full coverage of infant vaccinesup to 3 weeks after the intervention endsInfant's vaccination record or mother's recall based on a questionnaire
Perceived barriers to vaccinationImmediately before intervention starts, and up to 3 weeks after the intervention endsMother completes interviewer-administered questionnaire at specified times
Perceived susceptibility to vaccine-preventable diseases in childrenImmediately before intervention starts, and up to 3 weeks after the intervention endsMother completes interviewer-administered questionnaire at specified times
Timeliness of infant vaccinesup to 3 weeks after the intervention endsInfant's vaccination record or mother's recall based on interviewer-administered questionnaire
Perceived severity of vaccine-preventable diseases in childrenImmediately before intervention starts, and up to 3 weeks after the intervention endsMother completes interviewer-administered questionnaire at specified times
Cues to actionImmediately before intervention starts, and up to 3 weeks after the intervention endsMother completes interviewer-administered questionnaire at specified times
Perceived benefits of infant vaccinesImmediately before intervention starts, and up to 3 weeks after the intervention endsMother completes interviewer-administered questionnaire at specified times

Countries

Ethiopia, United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 17, 2026